MedTrace Logo

The Incremental Risk of Intraoperative Fentanyl on PONV

NCT03201315 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 363

Last updated 2019-08-06

No results posted yet for this study

Summary

The aim of this quality control study is to describe the presence and intensity of postoperative nausea and vomiting (PONV) and its correlation with intraoperative fentanyl dosing. Additionally, the investigators will examine pain scores.

Conditions

  • PONV

Sponsors & Collaborators

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Oliver Bandschapp, PD Dr. · University Hospital, Basel, Switzerland

  • Wilhelm Ruppen, PD Dr. · University Hospital, Basel, Switzerland

  • Eckhard Mauermann, MD, MSc · University Hospital Basel; University Hospital Ghent

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-01
Primary Completion
2017-05-31
Completion
2017-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03201315 on ClinicalTrials.gov